GODAVARI · GODAVARI DRUGS LTD. · Financials
Market Cap
1.24B INR
Shares
10.13M
Volume · Nov 13
26.06K
Avg daily vol (3M)
10.23K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
1.06B
-6.7%
FY2026
Net Income
40.89M
-6.6%
FY2026
Operating Cash Flow
7.34M
-93.4%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 1.12B | 1.06B | 1.13B |
| INR | 24.25M | 24.32M | 24.48M |
| INR | 38.02M | 39.8M | 47.32M |
| INR | 50.47M | 50.63M | 56.25M |
| INR | 9.33M | 9.74M | 12.45M |
| INR | 41.15M | 40.89M | 43.8M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.